ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00198172
Recruitment Status : Terminated (Accrual Goal Met)
First Posted : September 20, 2005
Last Update Posted : June 3, 2014
Sponsor:
Collaborator:
Indiana University
Information provided by:
Indiana University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Actual Study Completion Date : March 2007